Literature DB >> 2821114

Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.

A el-Hag1, R A Clark.   

Abstract

An in vitro model system was used to define the mechanism of interaction between human neutrophils and lymphocytes. Blood mononuclear leukocytes were exposed to purified neutrophils in the presence of a neutrophil-activating agent (phorbol ester, lectin, or opsonized particle). The treated mononuclear cells displayed a marked decrease in both natural killer activity and mitogen-dependent DNA synthesis, but no change in viability. This functional suppression was dependent on neutrophil number, stimulus concentration, and duration of exposure. Lymphocytes were protected by addition of catalase, but not superoxide dismutase. Neutrophils defective in oxidative metabolism (chronic granulomatous disease) failed to suppress lymphocyte function unless an H2O2-generating system, glucose oxidase plus glucose, was added. The patients' neutrophils provided a factor, possibly myeloperoxidase, which interacted with the glucose oxidase system. The immunosuppressive effect of normal neutrophils was diminished when chloride was omitted from the cultures and was enhanced when chloride was replaced by iodide. Myeloperoxidase-deficient neutrophils were partially defective in suppressing lymphocytes and this was corrected by addition of purified myeloperoxidase. Paradoxically, azide caused enhancement of suppression that depended on the neutrophil oxidative burst, but not on myeloperoxidase and was mediated at least in part by an effect of azide on the target mononuclear leukocytes. These data indicate that suppression of lymphocyte function by activated neutrophils is mediated by the secretion of myeloperoxidase and H2O2 that react with halides to form immunosuppressive products. Moreover, the mononuclear leukocytes contain an azide-sensitive factor, probably catalase, which provides partial protection against injury by neutrophil products. These dynamic interactions may be important local determinants of the immune response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  116 in total

1.  The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

Authors:  Sabine Krenn-Pilko; Uwe Langsenlehner; Tatjana Stojakovic; Martin Pichler; Armin Gerger; Karin S Kapp; Tanja Langsenlehner
Journal:  Tumour Biol       Date:  2015-07-29

2.  Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice.

Authors:  J Pedrosa; B M Saunders; R Appelberg; I M Orme; M T Silva; A M Cooper
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.

Authors:  Shun-Jun Fu; Shun-Li Shen; Shao-Qiang Li; Yun-Peng Hua; Wen-Jie Hu; Li-Jian Liang; Bao-Gang Peng
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

4.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

5.  Effects of anticoagulant, serum, and temperature on the natural killer activity of human peripheral blood mononuclear cells stored overnight.

Authors:  B K Son; R L Roberts; B J Ank; E R Stiehm
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

6.  Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.

Authors:  Young Wha Koh; Hee Jin Lee; Jin-Hee Ahn; Jong Won Lee; Gyungyub Gong
Journal:  Tumour Biol       Date:  2014-07-02

7.  Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer.

Authors:  Derya Kivrak Salim; Hasan Mutlu; Melek Karakurt Eryilmaz; Ozan Salim; Fatma Yalçin Musri; Deniz Tural; Şeyda Gündüz; Hasan Şenol Coşkun
Journal:  Mol Clin Oncol       Date:  2015-05-04

8.  Expression of Th1/Th2 cytokine mRNA in peritoneal exudative polymorphonuclear neutrophils and their effects on mononuclear cell Th1/Th2 cytokine production in MRL-lpr/lpr mice.

Authors:  C Yu; K Sun; C Tsai; Y Tsai; S Tsai; D Huang; S Han; H Yu
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

9.  The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

Authors:  Shouyu Wang; Zhen Zhang; Fengqi Fang; Xue Gao; Wei Sun; Huanran Liu
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

10.  Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.

Authors:  Mairéad G McNamara; Zarnie Lwin; Haiyan Jiang; Arnoud J Templeton; Gelareh Zadeh; Mark Bernstein; Caroline Chung; Barbara-Ann Millar; Normand Laperriere; Warren P Mason
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.